$31.82
+1.60 (+5.29%)
Performance
1D
—
1W
—
1M
—
3M
+3.41%
6M
-13.60%
1Y
-21.99%
YTD
+8.67%
Open$30.53
Previous Close$30.22
Day High$32.28
Day Low$30.45
52W High$46.48
52W Low$25.28
Volume—
Avg Volume2.03M
Market Cap4.53B
P/E Ratio10.12
EPS$2.78
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$30.02
Above
SMA 200
$32.89
Below
RSI (14)
46.3
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
15 analysts
Price Target
+96.1% upside
Current
$31.82
$31.82
Target
$62.39
$62.39
$43.17
$62.39 avg
$72.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 590.33M | 1.04B | 1.08B |
| Net Income | 428.34M | 129.57M | 136.18M |
| Profit Margin | 72.6% | 12.5% | 12.7% |
| EBITDA | 128.53M | 169.61M | 170.48M |
| Free Cash Flow | — | 110.01M | 140.89M |
| Rev Growth | +504.9% | +16.6% | +24.3% |
| Debt/Equity | 1.10 | 0.33 | 0.32 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |